Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Buy
68
INUV Quote, Financials, Valuation and Earnings
Last price:
$0.46
Seasonality move
:
234.51%
Day range:
$0.44 - $0.56
52-week range:
$0.19 - $0.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.67x
P/B ratio:
4.80x
Volume:
2.1M
Avg. volume:
788.3K
1-year change:
49.07%
Market cap:
$64.5M
Revenue:
$83.8M
EPS (TTM):
-$0.03
Analysts' Opinion
-
Consensus RatingInuvo has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $1.48, Inuvo has an estimated upside of 229.83% from its current price of $0.45.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.00 representing 100% downside risk from its current price of $0.45.
Fair Value
-
According to the consensus of 2 analysts, Inuvo has 229.83% upside to fair value with a price target of $1.48 per share.
INUV vs. S&P 500
-
Over the past 5 trading days, Inuvo has overperformed the S&P 500 by 5.93% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Inuvo does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Inuvo has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Inuvo reported revenues of $26.7M.
Earnings Growth
-
Inuvo earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Inuvo reported earnings per share of -$0.01.
Enterprise value:
61.9M
EV / Invested capital:
4.61x
Price / LTM sales:
0.67x
EV / EBIT:
--
EV / Revenue:
0.66x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-100.14x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$77.9M
Return On Assets:
-16.25%
Net Income Margin (TTM):
-5.25%
Return On Equity:
-36.12%
Return On Invested Capital:
-36.12%
Operating Margin:
-6.63%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $68.8M | $79.1M | $93.5M | $17M | $26.7M | |
| Gross Profit | $44.1M | $69.7M | $77.9M | $14.9M | $21.1M | |
| Operating Income | -$14M | -$9M | -$5.2M | -$2.1M | -$1.8M | |
| EBITDA | -$11.4M | -$5.7M | -$1.9M | -$1.4M | -$655.1K | |
| Diluted EPS | -$0.12 | -$0.08 | -$0.03 | -$0.02 | -$0.01 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $24.1M | $20.5M | $12.1M | $12.2M | $15.3M | |
| Total Assets | $44.5M | $41M | $30.2M | $29.8M | $31.7M | |
| Current Liabilities | $7.3M | $9.4M | $11.3M | $13.6M | $17.5M | |
| Total Liabilities | $8M | $9.8M | $11.5M | $14.7M | $18.2M | |
| Total Equity | $36.5M | $31.2M | $18.6M | $15.1M | $13.4M | |
| Total Debt | -- | -- | $592.9K | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$5.2M | -$678.7K | $1.2M | -$1.4M | -$366.9K | |
| Cash From Investing | $1.2M | -$1.7M | -$1.8M | -$472.2K | -$451.7K | |
| Cash From Financing | $240K | $2.9M | $748.7K | -$180.7K | $921.4K | |
| Free Cash Flow | -$6.9M | -$2.4M | -$618.6K | -$1.8M | -$818.6K | |
INUV
Sector
Market Cap
$64.5M
$80M
Price % of 52-Week High
56.6%
62.02%
Dividend Yield
0%
0%
Shareholder Yield
-2.21%
0.9%
1-Year Price Total Return
49.07%
-14.14%
Beta (5-Year)
0.984
0.841
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.44
200-day SMA
Buy
Level
$0.35
Bollinger Bands (100)
Buy
Level
0.37 - 0.51
Chaikin Money Flow
Sell
Level
-170.1M
20-day SMA
Buy
Level
$0.41
Relative Strength Index (RSI14)
Buy
Level
56.40
ADX Line
Buy
Level
27.93
Williams %R
Neutral
Level
-62.4371
50-day SMA
Buy
Level
$0.39
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
92
On Balance Volume
Neutral
Level
708M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.6644)
Sell
CA Score
(Annual)
Level (-0.3405)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (3.8695)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo’s revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Stock Forecast FAQ
In the current month, INUV has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The INUV average analyst price target in the past 3 months is $1.48.
-
Where Will Inuvo Stock Be In 1 Year?
According to analysts, the consensus estimate is that Inuvo share price will rise to $1.48 per share over the next 12 months.
-
What Do Analysts Say About Inuvo?
Analysts are divided on their view about Inuvo share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Inuvo is a Sell and believe this share price will drop from its current level to $1.00.
-
What Is Inuvo's Price Target?
The price target for Inuvo over the next 1-year time period is forecast to be $1.48 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is INUV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Inuvo is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of INUV?
You can purchase shares of Inuvo via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Inuvo shares.
-
What Is The Inuvo Share Price Today?
Inuvo was last trading at $0.46 per share. This represents the most recent stock quote for Inuvo. Yesterday, Inuvo closed at $0.45 per share.
-
How To Buy Inuvo Stock Online?
In order to purchase Inuvo stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is down 3.24% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 1.56% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is down 1.32% over the past day.
